Monogram Orthopaedics To Present Rescheduled Product Discussion With Surgeon Reaction During AAOS Annual Meeting

Monogram Biosciences Inc Com New Delist

Monogram Biosciences Inc Com New

MGRM

6.00

Delist

Event features Monogram's mBôs commercial robot alongside panel of orthopaedic surgeons

AUSTIN, TX / ACCESSWIRE / February 12, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgical robotics, hosted a recorded discussion of features of Monogram's mBôs and mVision technologies with a surgeon panel. Monogram's mVision technology is a novel approach to registration and tracking that the company is now working on for integration into the mBôs surgical robotic system in the future.

Below is an excerpt from the closing portion of the discussion and the product video that was played for the surgeon panel. The full discussion will be available separately via the registration link provided below.

Link: https://youtu.be/rnA6rwQbrIU

Ben Sexson, Chief Executive Officer, will present during the 2024 Canaccord Genuity Musculoskeletal Conference before attending the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting taking place February 12-16, 2024, in San Francisco.

Please use the link below to register to access a webcast of the full technical discussion of the mBôs and mVision technology suite with the surgeon panel.

Monogram Product Discussion Webcast

Date: Wednesday, February 21, 2024

Time: 11:00 a.m. CST

Webcast: https://streamyard.com/watch/AqQf7Hut8mVN

The AAOS Annual Meeting is the largest and most comprehensive orthopaedic educational experience in the world. Orthopaedic professionals from around the globe attend in pursuit of the latest clinical, scientific, surgical technology and practice management knowledge and expertise. To learn more, visit https://www.aaos.org/annual/.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via